Sejong, South Korea

Ki Myung Choi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Optipharm Co., Ltd. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki Myung Choi. Retrieved from https://idiyas.com/inventor/ki-myung-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Ki Myung CHOI

Introduction: Ki Myung CHOI is a distinguished inventor hailing from Sejong-si, South Korea. His passion for innovation and problem-solving has led to remarkable contributions in various fields.

Latest Patents: Ki Myung CHOI's latest patents showcase his expertise in cutting-edge technologies and solutions that are shaping the future of industries worldwide.

Career Highlights: Throughout his career, Ki Myung CHOI has demonstrated a keen ability to translate ideas into tangible inventions. His innovative spirit has earned him recognition as a trailblazer in the world of patents.

Collaborations: Ki Myung CHOI has collaborated with leading companies, research institutions, and universities to further his inventions and bring them to market. His partnerships have been instrumental in driving innovation forward.

Conclusion: In conclusion, Ki Myung CHOI's dedication to innovation and his relentless pursuit of excellence make him a standout figure in the world of inventors. His contributions continue to inspire and shape the landscape of technological advancements globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…